MED has a current Value of $24.84 per share. Therefore, it is undervalued compared to its Price of $14.25 per share.
MED has a Buy recommendation..
GRT (Earnings Growth Rate): GRT reflects a company's one to three year forecasted earnings growth rate in percent per year. MED has a forecasted Earnings Growth Rate of 28.00%, which VectorVest considers to be excellent.
EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. MED has a forecasted EPS of $0.66 per share.
P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. MED has a P/E of 21.59.
(from Vector Vest July 24, 2009)
Sales: MED has annual sales of $113,000,000.00
Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. MED has a Sales Growth of 28.00% per year. This is excellent. Sales Growth is updated each week for every stock. It is often useful to compare Sales Growth to Earnings Growth to gain an insight into a company's operations.
Sales Per Share (SPS): MED has annual sales of $7.92 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.
Price to Sales Ratio (P/S): MED has a P/S of 1.80. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.
Shares: MED has 14,000,000.00 shares of stock outstanding.
Market Capitalization: MED has a Market Capitalization of $205,000,000.00. Market Capitalization is calculated by multiplying price times shares outstanding.
